Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis
Manuscript Number:
18-0263R3
Author(s):
Edoardo Aromataris, Susan M. Bellman, Jared M. Campbell, Ian Chapman, Matthew D. Stephenson, Barbora de Courten
Disclosures
Edoardo Aromataris
Nothing to Disclose
Susan M. Bellman
Nothing to Disclose
Jared M. Campbell
Nothing to Disclose
Ian Chapman
Lecture Fees:
Lectures to health professionals (mainly general practitioners) on diabetes and its management. For Astra-Zeneca, Sanofi-Genzyme and Eli Lilly. None for companies making or related to metformin - the topic of this publication